Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Sun Pharmaceuticals Industries's Days Inventory or its related term are showing as below:
NSE:SUNPHARMA'
s Days Inventory Range Over the Past 10 Years
Min: 256.68 Med: 299.53 Max: 334.85
Current: 334.85
During the past 13 years, Sun Pharmaceuticals Industries's highest Days Inventory was 334.85. The lowest was 256.68. And the median was 299.53.
NSE:SUNPHARMA's Days Inventory is ranked worse than 88.49% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs NSE:SUNPHARMA: 334.85
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sun Pharmaceuticals Industries's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sun Pharmaceuticals Industries's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.79.
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sun Pharmaceuticals Industries's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sun Pharmaceuticals Industries's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sun Pharmaceuticals Industries Days Inventory Related Terms
Sun Pharmaceuticals Industries Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharmaceuticals Industries Days Inventory Chart
NSE:SUNPHARMA vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharmaceuticals Industries Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sun Pharmaceuticals Industries's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) has a Days Inventory of 158.80 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sun Pharmaceuticals Industries and its competitors. This is 47% below median its historical median of 299.53. Over the past decade, Sun Pharmaceuticals Industries' Days Inventory has ranged from 256.68 to 334.85. According to the industry distribution chart, Sun Pharmaceuticals Industries ranks #815 out of 921 companies in the Drug Manufacturers industry, placing it in the top 88.5%.
Is Sun Pharmaceuticals Industries' Days Inventory too high?
Sun Pharmaceuticals Industries' current Days Inventory of 158.80 is 47% below median its 10-year median of 299.53. Over the past 10 years, this metric has ranged from a low of 256.68 to a high of 334.85. The Drug Manufacturers industry median Days Inventory is 165.34. Sun Pharmaceuticals Industries' value of 158.80 is 4% below this industry median. Based on the distribution chart, Sun Pharmaceuticals Industries ranks #815 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sun Pharmaceuticals Industries ranks #815 out of 921 companies for Days Inventory. This places Sun Pharmaceuticals Industries in the lower half of its industry. The industry median Days Inventory is 165.34. Sun Pharmaceuticals Industries' value of 158.80 is 4% below this benchmark. Historically, Sun Pharmaceuticals Industries' own Days Inventory has ranged from 256.68 to 334.85 over the past decade. While the company's 10-year median is 299.53 vs. the industry median of 165.34, Sun Pharmaceuticals Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sun Pharmaceuticals Industries's current Days Inventory of 158.80 is 4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sun Pharmaceuticals Industries and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sun Pharmaceuticals Industries's current Days Inventory is 158.80, which is 47% below median its own 10-year median of 299.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (NSE:SUNPHARMA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,962.39, compared to a current price of ₹1,868.90 — trading 4.8% below its estimated fair value. The current Days Inventory is 158.80, which is 47% below median its 10-year median of 299.53 and 4% below the Drug Manufacturers industry median of 165.34. Sun Pharmaceuticals Industries' overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (NSE:SUNPHARMA), the current Days Inventory is 158.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Overvalued in 2026?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued.
The current stock price of ₹1,868.90 is trading 4.8% below its estimated GF Value™ of ₹1,962.39.
GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.
Key valuation signals for NSE:SUNPHARMA:
Days Inventory: 158.80 (47% below median its 10-year median of 299.53)
GF Value™: ₹1,962.39 vs. price of ₹1,868.90 (4.8% below fair value)
Industry Position: 4% below the Drug Manufacturers median (#815 of 921)
No single metric tells the full story. See the NSE:SUNPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
91GF Score
Get the complete analysis for NSE:SUNPHARMA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNPHARMA has been successfully added to your 
